Claro Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$312K Buy
+7,528
New +$303K 0.03% 392
2019
Q1
– Sell
-84
Closed -$2K – 447
2018
Q4
$2K Buy
+84
New +$1.81K ﹤0.01% 916

Other funds holding FTXH

Claro Advisors's FTXH Position: Q3 2026 in Review

Claro Advisors opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2026: 7,528 shares worth $312K. The stake represents 0.03% of the portfolio and ranks #392 among its holdings. This is a return to the name: Claro Advisors previously reported a position in FTXH as recently as Q4 2018.

Claro Advisors first reported a position in FTXH in Q4 2018 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.

  • Claro Advisors held 7,528 shares of First Trust Nasdaq Pharmaceuticals ETF worth $312K as of Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF was a new Claro Advisors position in Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF made up 0.03% of Claro Advisors's portfolio in Q3 2026, its #392 holding.
  • Claro Advisors first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2018 and has held it in 2 quarters since.
  • 71 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.

Based on Claro Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.